Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

Jan. 7, 1998

Antitussive properties of Chinoin xanthine explored

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Commencement of phase II trials of LiquiVent for adult ARDS

Dec. 31, 1997

IL-5 receptor ligands reported by Glaxo Wellcome

Dec. 31, 1997

New treatment approach for nasal congestion

Dec. 30, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....